Short latency afferent inhibition: A biomarker for mild cognitive impairment in Parkinson's disease?

Short latency afferent inhibition in Parkinson's disease patients with dementia

(2012) Ozlem Celebi et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS

(2012) Uzay E. Emir et al.   PLoS One

Reduced interhemispheric inhibition in mild cognitive impairment

(2012) Ryosuke Tsutsumi et al.   EXPERIMENTAL BRAIN RESEARCH

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

(2010) P. A. Kempster et al.   BRAIN

Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

(2009) Philipp M. Meyer et al.   ARCHIVES OF GENERAL PSYCHIATRY

Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD

(2009) Paul T. Francis   JOURNAL OF NEUROLOGY

Interactions between short-interval intracortical inhibition and short-latency afferent inhibition in human motor cortex

(2009) Henrik Alle et al.   JOURNAL OF PHYSIOLOGY-LONDON

Interactions between short latency afferent inhibition and long interval intracortical inhibition

(2009) Kaviraja Udupa et al.   EXPERIMENTAL BRAIN RESEARCH

Abnormal short latency afferent inhibition in early Alzheimer’s disease: a transcranial magnetic demonstration

(2008) Raffaele Nardone et al.   JOURNAL OF NEURAL TRANSMISSION